Shares of Cohance Lifesciences Ltd slipped nearly 5% to ₹918.00 on Thursday after a large block deal saw 8.9% equity change hands.
The transaction, valued at around $350 million, involved the sale of 34.1 million shares at a floor price of ₹900 per share, reflecting a discount of up to 6.9% from the stock’s previous close.
According to market sources, Jusmiral Holdings was the likely seller in the deal. On the buy side, the final buyers have not been officially confirmed.
The counter saw heavy trading volumes following the block deal, with investors reacting to the large equity change and discount pricing.
